PKM and breast cancer: PKM2 tetramers are highly enzymatically active and have a Km for phosphoenolpyruvate of 0.03 mM, whereas PKM2 mono/dimers are considerably less active with a Km of 0.46 mM as measured in breast cancer cells (Mazurek, 2011).